AQR Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,522
| Closed | -$175K | – | 2311 |
|
|
2023
Q1 | $175K | Sell |
6,522
-9,655
| -60% | -$260K | ﹤0.01% | 2069 |
|
|
2022
Q4 | $573K | Buy |
+16,177
| New | +$573K | ﹤0.01% | 1758 |
|
|
2020
Q4 | – | Sell |
-828
| Closed | -$202K | – | 2276 |
|
|
2020
Q3 | $202K | Sell |
828
-911
| -52% | -$222K | ﹤0.01% | 2053 |
|
|
2020
Q2 | $501K | Buy |
1,739
+33
| +2% | +$9.51K | ﹤0.01% | 1742 |
|
|
2020
Q1 | $348K | Buy |
+1,706
| New | +$348K | ﹤0.01% | 1708 |
|
|
2015
Q2 | – | Sell |
-32
| Closed | -$269K | – | 2269 |
|
|
2015
Q1 | $269K | Buy |
+32
| New | +$269K | ﹤0.01% | 1922 |
|